Literature DB >> 10577823

Hearing screening--aspects of epidemiology and identification of hearing impaired children.

A Parving1.   

Abstract

Mass screening of hearing in children is based on the concept of secondary prevention. In recognition of the importance of an early identification and intervention in children with congenital or early-acquired (i.e. neonatal period) hearing disability, numerous hearing screening programs have been introduced throughout the world. The devastating consequences of a congenital/early acquired hearing disability upon the speech, language, and social development of a child, and the estimated prevalence rates of at least 1-1.5/1000 live births of congenital permanent hearing impairment, represent an important health problem. The increase in the estimated prevalence of permanent hearing impairment in childhood, reaching at least 3.6-8.2% of live births at 5-9 years of age further emphasizes the importance of the problem. The delayed identification of children with congenital/early acquired hearing disability should result in the implementation of universal neonatal hearing screening, and the negative impact on the learning processes during school age from hearing impairment acquired throughout childhood seems to justify the introduction or maintenance of a hearing screening at school entrance. Implementation of efficient hearing screening programs throughout the neonatal period, infancy, or childhood should result in secondary prevention of this important health problem.

Entities:  

Mesh:

Year:  1999        PMID: 10577823     DOI: 10.1016/s0165-5876(99)00177-9

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Prevalence of hearing impairment in school children.

Authors:  Tahir Hussain; Abdullah A Alghasham; Muhammad Raza
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

2.  [Hearing screening at nursery schools: results of an evaluation study].

Authors:  Viktor Weichbold; Monika Rohrer; Cornelia Winkler; Kunigunde Welzl-Müller
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.